search

Active clinical trials for "Gallbladder Neoplasms"

Results 81-90 of 188

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular Carcinoma9 more

Phase II trial to study the effectiveness of erlotinib in treating patients who have unresectable liver, bile duct, or gallbladder cancer. Biological therapies such as erlotinib may interfere with the growth of cancer cells and slow the growth of the tumor.

Completed54 enrollment criteria

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary...

Extrahepatic Bile Duct CancerGallbladder Cancer1 more

RATIONALE: Drugs used in chemotherapy such as gemcitabine work in different ways to stop tumor cells from dividing so they stop growing or die. Pemetrexed disodium may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Combining gemcitabine with pemetrexed disodium may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of gemcitabine when given together with pemetrexed disodium to see how well it works in treating patients with unresectable or metastatic biliary tract or gallbladder cancer.

Completed43 enrollment criteria

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Anal CancerColorectal Cancer3 more

RATIONALE: Interleukin-12 may kill tumor cells by stimulating a person's white blood cells to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-12 in treating patients with cancer in the abdomen.

Completed3 enrollment criteria

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Breast CancerColorectal Cancer7 more

RATIONALE: Vaccines made from a person's white blood cells that have been treated in the laboratory may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have advanced or metastatic cancer.

Completed75 enrollment criteria

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors...

Colorectal CancerEsophageal Cancer9 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining gemcitabine, fluorouracil, and leucovorin in treating patients with recurrent, refractory, or metastatic solid tumors or lymphomas.

Completed50 enrollment criteria

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

Stage II Gallbladder CancerStage IIIA Gallbladder Cancer3 more

This phase II trial is studying how well giving 3-AP together with gemcitabine works in treating patients with unresectable or metastatic bile duct or gallbladder cancer. Drugs used in chemotherapy, such as 3-AP and gemcitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. 3-AP may help gemcitabine kill more cancer cells by making them more sensitive to the drug.

Completed20 enrollment criteria

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu...

Advanced Adult Primary Liver CancerAnaplastic Thyroid Cancer125 more

Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill cancer cells. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Phase I trial to study the effectiveness of interleukin-12 and trastuzumab in treating patients who have cancer that has high levels of HER2/neu and has not responded to previous therapy

Completed26 enrollment criteria

Biological Therapy in Treating Patients With Metastatic Cancer

Breast CancerColorectal Cancer10 more

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of biological therapy in treating patients who have metastatic cancer that has not responded to previous treatment.

Completed3 enrollment criteria

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer6 more

Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well lapatinib ditosylate works in treating patients with unresectable liver or biliary tract cancer

Completed99 enrollment criteria

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder...

Extrahepatic Bile Duct CancerGallbladder Cancer1 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have unresectable or metastatic biliary tract or gallbladder cancer.

Completed3 enrollment criteria
1...8910...19

Need Help? Contact our team!


We'll reach out to this number within 24 hrs